Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-18

FDA Approved: DIHYDROERGOTAMINE MESYLATE — Original Application (Gland Pharma Limited)

View source ↗

Summary

FDA approved the original application for dihydroergotamine mesylate from Gland Pharma Limited. This represents the approval of a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dihydroergotamine mesylate (Dihydroergotamine Mesylate)

Snippet

ORIG AP for DIHYDROERGOTAMINE MESYLATE (DIHYDROERGOTAMINE MESYLATE)